Abate-Shen C - Search Results

1

Intravesical delivery of rapamycin suppresses tumorigenesis in a mouse model of progressive bladder cancer.

Seager CM, Puzio-Kuter AM, Patel T, Jain S, Cordon-Cardo C, Mc Kiernan J, Abate-Shen C. Seager CM, et al. Cancer Prev Res (Phila). 2009 Dec;2(12):1008-14. doi: 10.1158/1940-6207.CAPR-09-0169. Epub 2009 Dec 1. Cancer Prev Res (Phila). 2009. PMID: 19952358 Free PMC article.

2

Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model.

Kinkade CW, Castillo-Martin M, Puzio-Kuter A, Yan J, Foster TH, Gao H, Sun Y, Ouyang X, Gerald WL, Cordon-Cardo C, Abate-Shen C. Kinkade CW, et al. J Clin Invest. 2008 Sep;118(9):3051-64. doi: 10.1172/JCI34764. J Clin Invest. 2008. PMID: 18725989 Free PMC article.

3

The untapped potential of genetically engineered mouse models in chemoprevention research: opportunities and challenges.

Abate-Shen C, Brown PH, Colburn NH, Gerner EW, Green JE, Lipkin M, Nelson WG, Threadgill D. Abate-Shen C, et al. Cancer Prev Res (Phila). 2008 Aug;1(3):161-6. doi: 10.1158/1940-6207.CAPR-08-0076. Cancer Prev Res (Phila). 2008. PMID: 19138951 Free PMC article. Review.

4

Inactivation of p53 and Pten promotes invasive bladder cancer.

Puzio-Kuter AM, Castillo-Martin M, Kinkade CW, Wang X, Shen TH, Matos T, Shen MM, Cordon-Cardo C, Abate-Shen C. Puzio-Kuter AM, et al. Genes Dev. 2009 Mar 15;23(6):675-80. doi: 10.1101/gad.1772909. Epub 2009 Mar 4. Genes Dev. 2009. PMID: 19261747 Free PMC article.

5

Simultaneous haploinsufficiency of Pten and Trp53 tumor suppressor genes accelerates tumorigenesis in a mouse model of prostate cancer.

Couto SS, Cao M, Duarte PC, Banach-Petrosky W, Wang S, Romanienko P, Wu H, Cardiff RD, Abate-Shen C, Cunha GR. Couto SS, et al. Differentiation. 2009 Jan;77(1):103-11. doi: 10.1016/j.diff.2008.09.010. Epub 2008 Oct 16. Differentiation. 2009. PMID: 19281769 Free PMC article.

6

Clinical outcomes after radical prostatectomy in diabetic patients treated with metformin.

Patel T, Hruby G, Badani K, Abate-Shen C, McKiernan JM. Patel T, et al. Urology. 2010 Nov;76(5):1240-4. doi: 10.1016/j.urology.2010.03.059. Urology. 2010. PMID: 20627287

7

Mouse models of human bladder cancer as a tool for drug discovery.

Seager C, Puzio-Kuter AM, Cordon-Cardo C, McKiernan J, Abate-Shen C. Seager C, et al. Curr Protoc Pharmacol. 2010 Jun;Chapter 14:Unit14.14. doi: 10.1002/0471141755.ph1414s49. Curr Protoc Pharmacol. 2010. PMID: 22294368 Free PMC article.

8

Dual targeting of the Akt/mTOR signaling pathway inhibits castration-resistant prostate cancer in a genetically engineered mouse model.

Floc'h N, Kinkade CW, Kobayashi T, Aytes A, Lefebvre C, Mitrofanova A, Cardiff RD, Califano A, Shen MM, Abate-Shen C. Floc'h N, et al. Cancer Res. 2012 Sep 1;72(17):4483-93. doi: 10.1158/0008-5472.CAN-12-0283. Epub 2012 Jul 19. Cancer Res. 2012. PMID: 22815528 Free PMC article.

9

B-Raf activation cooperates with PTEN loss to drive c-Myc expression in advanced prostate cancer.

Wang J, Kobayashi T, Floc'h N, Kinkade CW, Aytes A, Dankort D, Lefebvre C, Mitrofanova A, Cardiff RD, McMahon M, Califano A, Shen MM, Abate-Shen C. Wang J, et al. Cancer Res. 2012 Sep 15;72(18):4765-76. doi: 10.1158/0008-5472.CAN-12-0820. Epub 2012 Jul 25. Cancer Res. 2012. PMID: 22836754 Free PMC article.

10

Preclinical analyses of intravesical chemotherapy for prevention of bladder cancer progression.

Delto JC, Kobayashi T, Benson M, McKiernan J, Abate-Shen C. Delto JC, et al. Oncotarget. 2013 Feb;4(2):269-76. doi: 10.18632/oncotarget.852. Oncotarget. 2013. PMID: 23563166 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

126 results

Search Page

Filters